INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis
USA - NASDAQ:INNV - US45784A1043 - Common Stock
5.08 USD
+0.06 (+1.2%)
5.5 USD
+0.42 (+8.27%)
INNV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While INNV seems to be doing ok healthwise, there are quite some concerns on its profitability. INNV is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year INNV has reported negative net income.
INNV had a positive operating cash flow in the past year.
In the past 5 years INNV always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: INNV reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -5.75%, INNV is not doing good in the industry: 70.30% of the companies in the same industry are doing better.
INNV has a Return On Equity of -12.90%. This is in the lower half of the industry: INNV underperforms 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.75% | ||
| ROE | -12.9% | ||
| ROIC | N/A |
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of INNV (18.00%) is worse than 63.37% of its industry peers.
INNV's Gross Margin has declined in the last couple of years.
INNV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
2. Health
2.1 Basic Checks
INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
INNV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for INNV has been increased compared to 5 years ago.
The debt/assets ratio for INNV has been reduced compared to a year ago.
2.2 Solvency
INNV has an Altman-Z score of 2.68. This is not the best score and indicates that INNV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of INNV (2.68) is comparable to the rest of the industry.
The Debt to FCF ratio of INNV is 2.72, which is a good value as it means it would take INNV, 2.72 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.72, INNV is doing good in the industry, outperforming 79.21% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that INNV is not too dependend on debt financing.
INNV has a Debt to Equity ratio of 0.28. This is in the better half of the industry: INNV outperforms 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.72 | ||
| Altman-Z | 2.68 |
ROIC/WACCN/A
WACC9.1%
2.3 Liquidity
INNV has a Current Ratio of 1.07. This is a normal value and indicates that INNV is financially healthy and should not expect problems in meeting its short term obligations.
INNV has a worse Current ratio (1.07) than 69.31% of its industry peers.
A Quick Ratio of 1.07 indicates that INNV should not have too much problems paying its short term obligations.
The Quick ratio of INNV (1.07) is worse than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
INNV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
INNV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.76%.
The Revenue has been growing by 8.52% on average over the past years. This is quite good.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.76%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%11.04%
3.2 Future
The Earnings Per Share is expected to grow by 77.26% on average over the next years. This is a very strong growth
INNV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.21% yearly.
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INNV. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 33.20, INNV can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as INNV.
When comparing the Price/Forward Earnings ratio of INNV to the average of the S&P500 Index (22.88), we can say INNV is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.2 |
4.2 Price Multiples
64.36% of the companies in the same industry are cheaper than INNV, based on the Enterprise Value to EBITDA ratio.
INNV's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.9 | ||
| EV/EBITDA | 180 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INNV's earnings are expected to grow with 77.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y101.79%
EPS Next 3Y77.26%
5. Dividend
5.1 Amount
INNV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
5.08
+0.06 (+1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners12.08%
Inst Owner Change0.04%
Ins Owners1.96%
Ins Owner Change0.38%
Market Cap689.05M
Revenue(TTM)853.70M
Net Income(TTM)-30313000
Analysts46.67
Price Target5.95 (17.13%)
Short Float %1.4%
Short Ratio5.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-234.74%
Min EPS beat(2)-527.45%
Max EPS beat(2)57.98%
EPS beat(4)1
Avg EPS beat(4)-191.55%
Min EPS beat(4)-527.45%
Max EPS beat(4)57.98%
EPS beat(8)3
Avg EPS beat(8)-94.7%
EPS beat(12)4
Avg EPS beat(12)-88.87%
EPS beat(16)5
Avg EPS beat(16)-94.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.67%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)-0.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.25%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)-0.1%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)0%
PT rev (3m)2.94%
EPS NQ rev (1m)200%
EPS NQ rev (3m)150%
EPS NY rev (1m)20%
EPS NY rev (3m)200%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.2 | ||
| P/S | 0.81 | ||
| P/FCF | 25.9 | ||
| P/OCF | 20.97 | ||
| P/B | 2.93 | ||
| P/tB | 7.74 | ||
| EV/EBITDA | 180 |
EPS(TTM)-0.16
EYN/A
EPS(NY)0.15
Fwd EY3.01%
FCF(TTM)0.2
FCFY3.86%
OCF(TTM)0.24
OCFY4.77%
SpS6.29
BVpS1.73
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.75% | ||
| ROE | -12.9% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18% | ||
| FCFM | 3.12% |
ROA(3y)-5.61%
ROA(5y)-5.25%
ROE(3y)-11.52%
ROE(5y)-9.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.44%
GM growth 5Y-6.3%
F-Score6
Asset Turnover1.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.28 | ||
| Debt/FCF | 2.72 | ||
| Debt/EBITDA | 19.32 | ||
| Cap/Depr | 32.1% | ||
| Cap/Sales | 0.73% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 976.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 2.68 |
F-Score6
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)75.1%
Cap/Depr(5y)131.8%
Cap/Sales(3y)1.72%
Cap/Sales(5y)2.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y195.62%
EPS Next 2Y101.79%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)11.76%
Revenue growth 3Y6.91%
Revenue growth 5Y8.52%
Sales Q2Q%11.04%
Revenue Next Year8.7%
Revenue Next 2Y9.18%
Revenue Next 3Y9.21%
Revenue Next 5YN/A
EBIT growth 1Y30.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year295.43%
EBIT Next 3Y74.87%
EBIT Next 5YN/A
FCF growth 1Y159.37%
FCF growth 3YN/A
FCF growth 5Y-3.62%
OCF growth 1Y189.07%
OCF growth 3Y6.38%
OCF growth 5Y-5.59%
INNOVAGE HOLDING CORP / INNV FAQ
Can you provide the ChartMill fundamental rating for INNOVAGE HOLDING CORP?
ChartMill assigns a fundamental rating of 3 / 10 to INNV.
Can you provide the valuation status for INNOVAGE HOLDING CORP?
ChartMill assigns a valuation rating of 3 / 10 to INNOVAGE HOLDING CORP (INNV). This can be considered as Overvalued.
What is the profitability of INNV stock?
INNOVAGE HOLDING CORP (INNV) has a profitability rating of 1 / 10.